Quantitative apparent diffusion coefficient measurement obtained by 3.0Tesla MRI as a potential noninvasive marker of tumor aggressiveness in breast cancer.

[1]  S. Mugikura,et al.  Peritumoral apparent diffusion coefficients for prediction of lymphovascular invasion in clinically node-negative invasive breast cancer , 2016, European Radiology.

[2]  T. Helbich,et al.  Quantitative Apparent Diffusion Coefficient as a Noninvasive Imaging Biomarker for the Differentiation of Invasive Breast Cancer and Ductal Carcinoma In Situ , 2015, Investigative radiology.

[3]  Jamie R. Kutasovic,et al.  Invasive lobular carcinoma of the breast: morphology, biomarkers and ’omics , 2015, Breast Cancer Research.

[4]  S. Hahn,et al.  Correlations between apparent diffusion coefficient values of invasive ductal carcinoma and pathologic factors on diffusion‐weighted MRI at 3.0 Tesla , 2015, Journal of magnetic resonance imaging : JMRI.

[5]  Louisa Bokacheva,et al.  Intravoxel incoherent motion diffusion‐weighted MRI at 3.0 T differentiates malignant breast lesions from benign lesions and breast parenchyma , 2014, Journal of magnetic resonance imaging : JMRI.

[6]  Hauke Bartsch,et al.  Diffusion-weighted imaging in cancer: physical foundations and applications of restriction spectrum imaging. , 2014, Cancer research.

[7]  Shou‐Tung Chen,et al.  Tumor characteristics of breast cancer in predicting axillary lymph node metastasis , 2014, Medical science monitor : international medical journal of experimental and clinical research.

[8]  R. Nunes,et al.  Diffusion-weighted imaging: determination of the best pair of b-values to discriminate breast lesions. , 2014, The British journal of radiology.

[9]  Hiroshi Honda,et al.  Diagnostic and Prognostic Value of Pretreatment SUV in 18F-FDG/PET in Breast Cancer: Comparison with Apparent Diffusion Coefficient from Diffusion-Weighted MR Imaging , 2014, The Journal of Nuclear Medicine.

[10]  Y. Hasegawa,et al.  EGFR-TKI resistance due to BIM polymorphism can be circumvented in combination with HDAC inhibition. , 2013, Cancer research.

[11]  T. Yoshiura,et al.  Correlations between apparent diffusion coefficient values and prognostic factors of breast cancer. , 2013, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.

[12]  Lorenzo Bonomo,et al.  Magnetic resonance imaging features in triple-negative breast cancer: comparison with luminal and HER2-overexpressing tumors. , 2012, Clinical breast cancer.

[13]  H J Kim,et al.  Correlation of the apparent diffusion coefficiency values on diffusion-weighted imaging with prognostic factors for breast cancer. , 2012, The British journal of radiology.

[14]  Eun-Kyung Kim,et al.  Triple-negative invasive breast cancer on dynamic contrast-enhanced and diffusion-weighted MR imaging: comparison with other breast cancer subtypes , 2012, European Radiology.

[15]  R. Ponzone,et al.  Correlations between diffusion-weighted imaging and breast cancer biomarkers , 2012, European Radiology.

[16]  Kornelia Polyak,et al.  Heterogeneity in breast cancer. , 2011, The Journal of clinical investigation.

[17]  M. Park,et al.  The Role of Lymphovascular Invasion as a Prognostic Factor in Patients with Lymph Node-Positive Operable Invasive Breast Cancer , 2011, Journal of breast cancer.

[18]  Sung Hun Kim,et al.  Correlation of the apparent diffusion coefficient value and dynamic magnetic resonance imaging findings with prognostic factors in invasive ductal carcinoma , 2011, Journal of magnetic resonance imaging : JMRI.

[19]  N. Harbeck,et al.  A new look at node-negative breast cancer. , 2010, The oncologist.

[20]  L. Bonomo,et al.  Diffusion-weighted imaging in breast cancer: relationship between apparent diffusion coefficient and tumour aggressiveness. , 2010, Clinical radiology.

[21]  R. Matsubayashi,et al.  Apparent Diffusion Coefficient in Invasive Ductal Breast Carcinoma: Correlation with Detailed Histologic Features and the Enhancement Ratio on Dynamic Contrast-Enhanced MR Images , 2010, Journal of oncology.

[22]  Shu Ichihara,et al.  Breast cancer prognostic classification in the molecular era: the role of histological grade , 2010, Breast Cancer Research.

[23]  Katarzyna J Macura,et al.  Diffusion-weighted imaging improves the diagnostic accuracy of conventional 3.0-T breast MR imaging. , 2010, Radiology.

[24]  A. Razek,et al.  Invasive ductal carcinoma: correlation of apparent diffusion coefficient value with pathological prognostic factors , 2010, NMR in biomedicine.

[25]  Ying Yuan,et al.  Accuracy of MRI in prediction of pathologic complete remission in breast cancer after preoperative therapy: a meta-analysis. , 2010, AJR. American journal of roentgenology.

[26]  Wendy B DeMartini,et al.  Apparent diffusion coefficient values for discriminating benign and malignant breast MRI lesions: effects of lesion type and size. , 2010, AJR. American journal of roentgenology.

[27]  Ming-Chih Chou,et al.  Breast cancer heterogeneity: mechanisms, proofs, and implications , 2010, Journal of Cancer.

[28]  B. Kang,et al.  Diffusion‐weighted imaging of breast cancer: Correlation of the apparent diffusion coefficient value with prognostic factors , 2009, Journal of magnetic resonance imaging : JMRI.

[29]  W. Gradishar,et al.  New Molecular Classifications of Breast Cancer , 2009, CA: a cancer journal for clinicians.

[30]  Zhuang Liu,et al.  Drug delivery with carbon nanotubes for in vivo cancer treatment. , 2008, Cancer research.

[31]  Les Irwig,et al.  Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  R W Blamey,et al.  Prognostic value of lymphovascular invasion in women with lymph node negative invasive breast carcinoma. , 2006, European journal of cancer.

[33]  Michael Gnant,et al.  Prognostic Value of Lymphangiogenesis and Lymphovascular Invasion in Invasive Breast Cancer , 2004, Annals of surgery.

[34]  M. Héry,et al.  Natural history of node-negative breast cancer: are conventional prognostic factors predictors of time to relapse? , 2002, Breast.